Terms: = Liver cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
71 results:
1. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
2. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
3. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Flecchia C; Auclin E; Alouani E; Mercier M; Hollebecque A; Turpin A; Mazard T; Pernot S; Dutherage M; Cohen R; Borg C; Hautefeuille V; Sclafani F; Ben-Abdelghani M; Aparicio T; De La Fouchardière C; Herve C; Perkins G; Heinrich K; Kunzmann V; Gallois C; Guimbaud R; Tougeron D; Taieb J
Br J Cancer; 2024 Feb; 130(3):442-449. PubMed ID: 38102227
[TBL] [Abstract] [Full Text] [Related]
4. Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.
Zheng L; Zhang X; Nian Y; Zhou W; Li D; Wu Y
BMC Gastroenterol; 2023 Nov; 23(1):386. PubMed ID: 37951862
[TBL] [Abstract] [Full Text] [Related]
5. Yttrium-90 Transarterial Radioembolization of Primary Lung cancer Metastases to the liver.
Alexander ES; Petre EN; Zhao K; Sotirchos V; Namakydoust A; Moussa A; Yuan G; Sofocleous CT; Solomon SB; Ziv E
J Vasc Interv Radiol; 2024 Feb; 35(2):214-225.e2. PubMed ID: 37923172
[TBL] [Abstract] [Full Text] [Related]
6. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications.
Krajnović M; Kožik B; Božović A; Jovanović-Ćupić S
Cells; 2023 Sep; 12(18):. PubMed ID: 37759525
[TBL] [Abstract] [Full Text] [Related]
7. cancer survival analysis and spatial distribution during 2014-2016 in Shandong Province, China.
Jiang F; Fu Z; Lu Z; Chu J; Xu A; Guo X; Ma J
Sci Rep; 2023 Jun; 13(1):10324. PubMed ID: 37365230
[TBL] [Abstract] [Full Text] [Related]
8. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
[TBL] [Abstract] [Full Text] [Related]
9. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).
Tinguely P; Ruiter SJS; Engstrand J; de Haas RJ; Nilsson H; Candinas D; de Jong KP; Freedman J
Eur J Cancer; 2023 Jul; 187():65-76. PubMed ID: 37119639
[TBL] [Abstract] [Full Text] [Related]
10. Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis.
Brown TJ; Mamtani R; Gimotty PA; Karasic TB; Yang YX
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2345-2354. PubMed ID: 36862158
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
[TBL] [Abstract] [Full Text] [Related]
12. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract] [Full Text] [Related]
13. The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China.
Meng R; Cao Y; Zhou T; Hu H; Qiu Y
Front Public Health; 2022; 10():794131. PubMed ID: 35433574
[TBL] [Abstract] [Full Text] [Related]
14. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
15. Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression.
Ji F; Zhang J; Liu N; Gu Y; Zhang Y; Huang P; Zhang N; Lin S; Pan R; Meng Z; Feng XH; Roessler S; Zheng X; Ji J
Gut; 2022 Nov; 71(11):2313-2324. PubMed ID: 34996827
[TBL] [Abstract] [Full Text] [Related]
16. Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma.
Suh YJ; Jin YJ; Jeong Y; Shin WY; Lee JM; Cho S; Yu JH; Lee JW
Medicine (Baltimore); 2021 Oct; 100(43):e27470. PubMed ID: 34713824
[TBL] [Abstract] [Full Text] [Related]
17. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
Pullarkat ST; Wu W; Pullarkat V
Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
[TBL] [Abstract] [Full Text] [Related]
18. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Nadarevic T; Giljaca V; Colli A; Fraquelli M; Casazza G; Miletic D; Štimac D
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013362. PubMed ID: 34611889
[TBL] [Abstract] [Full Text] [Related]
19. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
20. Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in treatment-naïve Chronic Hepatitis B Patients in Korea.
Choi H; Seo GH
J Korean Med Sci; 2021 Apr; 36(14):e89. PubMed ID: 33847080
[TBL] [Abstract] [Full Text] [Related]
[Next]
